James W. Ironside

Active 1989–2022

Also published as
James W Ironside
117
Papers
28,212
Citations
92
h-index
116
i10-index

Citations

Citations per year for James W. Ironside1922: 1 citations1990: 3 citations1991: 4 citations1992: 2 citations1993: 2 citations1994: 14 citations1995: 15 citations1996: 41 citations1997: 109 citations1998: 114 citations1999: 162 citations2000: 192 citations2001: 232 citations2002: 187 citations2003: 269 citations2004: 319 citations2005: 265 citations2006: 304 citations2007: 191 citations2008: 230 citations2009: 163 citations2010: 203 citations2011: 146 citations2012: 119 citations2013: 122 citations2014: 113 citations2015: 104 citations2016: 162 citations2017: 165 citations2018: 169 citations2019: 510 citations2020: 541 citations2021: 553 citations2022: 395 citations2023: 248 citations2024: 389 citations2025: 162 citations2026: 8 citations1923–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,836 citing papers, 24.6% of this breakdownUnited Kingdom: 1,089 citing papers, 14.6% of this breakdownGermany: 551 citing papers, 7.4% of this breakdownItaly: 480 citing papers, 6.4% of this breakdownCanada: 329 citing papers, 4.4% of this breakdownFrance: 324 citing papers, 4.3% of this breakdownNetherlands: 258 citing papers, 3.5% of this breakdownSpain: 247 citing papers, 3.3% of this breakdownAustralia: 227 citing papers, 3% of this breakdownSwitzerland: 227 citing papers, 3% of this breakdownChina: 205 citing papers, 2.8% of this breakdownJapan: 204 citing papers, 2.7% of this breakdown
0%24.6%Other 20%

Fields

  • Medicine49.6%
  • Biochemistry, Genetics and Molecular Biology39.6%
  • Neuroscience5.7%
  • Immunology and Microbiology2.1%
  • Agricultural and Biological Sciences0.5%
  • Computer Science0.4%
  • Other2.1%

Topics

  • Prion Diseases and Protein Misfolding12.9%
  • Alzheimer's disease research and treatments9.5%
  • Neurological diseases and metabolism6.3%
  • Parkinson's Disease Mechanisms and Treatments4.3%
  • Dementia and Cognitive Impairment Research4.1%
  • Glioma Diagnosis and Treatment3.8%
  • Other59.1%

Coauthors

All papers

Open in search
  1. Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies

    Authors: , , , , , , , , , , , , , , , - Annals of Clinical and Translational Neurology 2016 cited by 613

  2. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giorgio Giaccone, Kimmo J. Hatanpaa, Richard Heale, Patrick R. Hof, Monika Hofer, Tibor Hortobágyi, K. A. Jellinger, Gregory A. Jicha, Paul G. Ince, Julia Kofler, Enikò Kövari, Jillian J. Kril, David Mann, Radoslav Matěj, Ann C. McKee, Catriona McLean, Ivan Milenković, Thomas J. Montine, Shigeo Murayama, Edward B. Lee, Jasmin Rahimi, Roberta Diehl Rodriguez, Annemieke J.M. Rozemüller, Julie A. Schneider, Christian Schultz, William W. Seeley, Danielle Seilhean, Colin Smith, Fabrizio Tagliavini, Masaki Takao, Dietmar Rudolf Thal, Jon B. Toledo, Markus Tolnay, Juan C. Troncoso, Harry V. Vinters, Serge Weis, Stephen B. Wharton, Charles L. White, Thomas Wısnıewskı, John Woulfe, Masahito Yamada, Dennis W. Dickson - Acta Neuropathologica 2015 cited by 530

  3. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2015 cited by 609

  4. Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment

    Authors: , , , , , , , , , , , , - Brain 2016 cited by 316

  5. Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2009 cited by 329

  6. Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2017 cited by 146

  7. Serpin Signatures in Prion and Alzheimer’s Diseases

    Authors: , , , , , , , , , , , , , , - Molecular Neurobiology 2022 cited by 80

  8. A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , C Kalifa, Marie‐Anne Raquin, Joris Verlooy, Volkmar Hans, Torsten Pietsch, Wolfram Scheurlen, Johannes A. Hainfellner, Felice Giangaspero, James W. Ironside, Keith Robson, Kari Skullerud, David Scheie, Nn Nn, Marie-Madeleine Ruchoux, Anne Jouvet, Dominique Figarella‐Branger, Arielle Lellouch-Toubiana, Monika Warmuth‐Metz, Daniela Prayer, Milena Calderone, Tim Jaspan, S. J. Bakke, Eli Abraham Vázquez, D. Couanet, Rolf D. Kortmann, Karin Diekmann, Giovanni Scarzello, Roger Taylor, Knut Lote, J. Giralt, C. Carrié, Jean Louis Habrand, Niels Soerensen, Thomas Czech, Paul Chumas, Bengt Gustavson, Michel Zérah, Bettina Wabbels, Maria Luisa Pinello, Alistair R. Fielder, Ian Simmons, Terje Christoffersen, Gabriele Calaminus, Knut Brockmann, Ronald Straeter, Friedrich Ebinger, Pablo Hernáiz Driever, Herwig Lackner, Colin Kennedy, Adam Glaser, Bo Strömberg, José M. Indiano, C Rodary, Éric Bouffet, Didier Frappaz, Andreas Faldum, Angela Emser, Gian Luca De Salvo, Suzanne Stephens, David Machin, Marie‐Cécile Le Deley, Thore Egeland, Carolyn Freemann, Martin Schrappe, Richard Sposto, Martin Schrappe, Richard Sposto - European Journal of Cancer 2017 cited by 152

  9. Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains

    Authors: , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica Communications 2017 cited by 136

  10. Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA

    Authors: , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2012 cited by 232

  11. Influence of Intracerebral Hemorrhage Location on Incidence, Characteristics, and Outcome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rod Gibson, Claire Gordon, Robin Grant, Russell Hewett, Fiona Hughes, Mark Hughes, David Hunt, Neil Hunter, James W. Ironside, Imran Liaquat, Colin B. Josephson, Anant Kamat, Susan Kealley, Sarah Keir, G.R. Kerr, Simon Kerrigan, Peter Keston, Matthew D. King, Richard Knight, Elizabeth Macdonald, Graham Mackay, Donald Macleod, Malcolm Macleod, Conor Maguire, Steven Makin, Ashok Mathews, Fiona Maxwell, Stuart McClellan, Tracey Millar, Zoë Morris, Tim Morse, C J Mumford, Katherine Murray, Lynn Myles, Graham R. Nimmo, Yi Shiau Ng, Suvankar Pal, Kristiina Rannikmäe, Jonathan Rhodes, Jerard Ross, T. Turner Russell, Peter Sandercock, Robin Sellar, Mano Shanmuganathan, Himanshu Shekhar, H. Neil Simms, M. Sittampalam, Hamza Soleiman, Helen Spiers, Patrick Statham, Neo Stavrinos, Jon Stone, Joyce Stuart, Cathie Sudlow, David Summers, Pat Taylor, Antonia Torgersen, Margarethe van Dijke, Robert Walker, Belinda Weller, William Whiteley, Ian R. Whittle, Robert Will, Wendy B. Young, Judith Anderson, Seona Broadbent, Laura Butler, Dave Caesar, Patricia Cantley, Jonathan Carter and 63 more - Stroke 2015 cited by 169

  12. A new variant of Creutzfeldt-Jakob disease in the UK

    Authors: , , , , , , , , , - The Lancet 1996 cited by 2,698

  13. Prions in the Urine of Patients with Variant Creutzfeldt–Jakob Disease

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 215

  14. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manuel A. Friese, Olga Pletnikova, Miren Zulaica, Carmen Lage, Itziar de Rojas, Steffi G. Riedel‐Heller, Ignacio Illán‐Gala, Wei Wei, Bernard Jeune, Adelina Orellana, Florian Then Bergh, Xue Wang, Marc Hulsman, Nina Beker, Niccoló Tesi, Christopher M. Morris, Begoña Indakoetxea, Lyduine E. Collij, Martin Scherer, Estrella Morenas‐Rodríguez, James W. Ironside, Bart N.M. van Berckel, Daniel Alcolea, Heinz Wiendl, Samantha L. Strickland, Pau Pástor, Eloy Rodríguez‐Rodríguez, Bradley F. Boeve, Ronald C. Petersen, Tanis J. Ferman, Jay A. van Gerpen, Marcel Reinders, Ryan J. Uitti, Lluís Tárraga, Wolfgang Maier, Oriol Dols‐Icardo, Amit Kawalia, Carolina Dalmasso, Merçé Boada, Uwe K. Zettl, Natasja M. van Schoor, Marian Beekman, Mariet Allen, Eliezer Masliah, Adolfo López de Munain, Alexander Pantelyat, Zbigniew K. Wszołek, Owen A. Ross, Dennis W. Dickson, Caroline Graff, David S. Knopman, Rosa Rademakers, Afina W. Lemstra, Yolande A.L. Pijnenburg, Philip Scheltens, Thomas Gasser, Patrick F. Chinnery, Bernhard Hemmer, Martijn Huisman, Juan C. Troncoso, Fermín Moreno, Ellen A. Nøhr, Thorkild I. A. Sørensen, Peter Heutink, Pascual Sánchez‐Juan, Daniëlle Posthuma, Jordi Clarimón, Kaare Christensen, Nilüfer Ertekin‐Taner, Sonja W. Scholz and 5 more - Acta Neuropathologica 2019 cited by 131

  15. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection

    Authors: , , , , , , , , , , , , , , , - Acta Neuropathologica Communications 2016 cited by 101

  16. A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702)

    Authors: , , , , , , , - Neuro-Oncology 2010 cited by 205

  17. Assessment of β-amyloid deposits in human brain: a study of the BrainNet Europe Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Walter Schulz‐Schaeffer, Nathalie Streichenberger, Stephen B. Wharton, Hans A. Kretzschmar - Acta Neuropathologica 2009 cited by 192

  18. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent

    Authors: , , , , , , , , , , , , - Nature 1997 cited by 1,980

  19. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD

    Authors: , , , , - Nature 1996 cited by 1,732

  20. Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease

    Authors: , , , , , , - Science Translational Medicine 2016 cited by 165

  21. The Apolipoprotein E ε2 Allele and the Pathological Features in Cerebral Amyloid Angiopathy-related Hemorrhage

    Authors: , , , , , , , - Journal of Neuropathology & Experimental Neurology 1999 cited by 160

  22. Sensitive and specific detection of sporadic Creutzfeldt–Jakob disease brain prion protein using real-time quaking-induced conversion

    Authors: , , , , , , , , , , , - Journal of General Virology 2011 cited by 134

  23. Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Nuclear Medicine 2016 cited by 103

  24. Neuropathological Diagnostic Criteria for Creutzfeldt‐Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases)

    Authors: , , , , , , , , , , , , , , , - Brain Pathology 1995 cited by 428